PUBLISHED DATE : Sep 2020 | Pages : 286
Fill out your details & get your free sample
Embolic Protection Market Size, Share, & Trends Analysis Report By Product (Filters, Occlusions), By Application (Cardiovascular & Peripheral, Neurovascular), By Indication (SVG, Carotid Artery Diseases, Others), By End-user (Hospitals, Specialty Cardiac Centers, ASCs, Freestanding CATH Labs), By Geography (North America, Europe, APAC, Latin America, and the Middle East & Africa) Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020 – 2025
286 Pages
73 Tables
147 Charts
5 Regions
18 Countries
16 Companies
5 Market Segment
| Report Attribute | Details |
|---|---|
| MARKET SIZE (REVENUE) | USD 688 Million |
| CAGR | 8% (2020-2025) |
| Base Year | 2019 |
| Forecast Year | 2020-2025 |
| Market Segmentation | Application (Cardiovascular & Peripheral, Neurovascular), By Indication (SVG, Carotid Artery Diseases, Others), By End-user (Hospitals, Specialty Cardiac Centers, ASCs, Freestanding CATH Labs) |
| Geographical Analysis | North America, Europe, APAC, Latin America, and Middle East & Africa |
| Countries Covered | US, Canada, UK, Germany, France, Spain, Italy, China, Japan, South Korea, Australia, India, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, and UAE |
The global embolic protection devices market size is expected to grow at a CAGR of 8% to reach USD 688 million by 2025. The market is growing mainly due to the rising cardiovascular and neurovascular diseases across the globe. Globally, such diseases are primarily caused by several factors, including obesity, lack of physical activities, and hypertension. Epidemiological studies have reported that cardiac and neuro diseases are recognized as the leading cause of morbidity and mortality worldwide. Several factors influence the growth of the global embolic protection devices market. The rising demand for cerebral embolic protection devices is expected to drive the growth of the market. Growing demand for cerebral protection while performing neurovascular surgeries such as carotid artery stenting is another driving factor for the global embolic protection devices market.
This research report includes a detailed segmentation by
The filter devices segment accounts for the maximum market share. This is due to effective clinical results for percutaneous and transcatheter surgical techniques to treat cardiac and neuro disorders. It is expected to grow at the highest CAGR owing to greater safety and procedural outcomes. The high success rate and the growing patient pool for several cardiac and neuro diseases is likely to influence segment growth. The filter devices have a larger profile than the occlusion devices segment. Availability of latest-generation devices Such as ANGIOGUARD RX Guidewire System, by Cardinal Health & FilterWire EZ by Boston Scientific, is driving the growth of the filter devices segment.
The occlusion devices segment is expected to reach over $100 million by 2025. Improved procedural outcomes for several occlusion devices, which aim to reduce or eliminate distal embolization during percutaneous coronary and carotid interventions, have increased the adoption of occlusion devices.
The cardiac & peripheral segment is expected to retain its market dominance during the forecast period. Filter or occlusion embolic protection devices have proven clinical benefits and can be used when technically feasible for cardiac & peripheral applications. As a result, there is a huge demand for EPDs for treating CVDs across the globe. While APAC is expected to grow at the highest CAGR, North America is likely to retain dominance in the market.
The demand for several embolic protection devices (EPD) is growing steadily for neuro applications such as Carotid Artery Stenting (CAS). Several major and emerging vendors are offering innovative EPDs to reduce the risk of stroke due to embolic events. Moreover, the availability of integrated and advanced embolic protection devices is likely to drive the growth of the neuro application segment.
Despite potential growth opportunities of EPDs to treat saphenous vein graft (SVG), the recent eruption of the COVID-19 pandemic is causing unprecedented challenges to perform PCI procedures. The spread of the virus has disrupted daily lives with educational and commercial institutions shutting down across cities or countries and travel and large gatherings prohibited.
EPDs have become a standard for anatomically suitable patients undergoing SVG PCI. Therefore, many players have been focusing on the development of clinically advanced EPD for SVG disease over the years. This is increasing the global embolic protection devices market size.
Carotid artery stenting (CAS) is considered as the preferred treatment for patients with symptomatic carotid stenosis. The use of embolic protection devices is feasible and safe for patients with a low incidence of neurology complications. Therefore, several vendors are strategizing to develop and commercialize embolic protection devices for carotid interventions.
Healthcare professionals in hospitals use advanced embolic protection stents for cardiac & peripheral and neuro procedures. The market is growing at a healthy rate primarily due to the higher adoption of latest generation EPDs, as a majority of patients prefer to visit hospitals. The aging population and the increasing pool of patient populations with CVDs and neuro disease are the major factors driving the market growth of the hospital segment.
Specialty cardiac centers have a high number of highly skilled cardiac surgeons. They perform modern procedures such as PCI, Transcatheter aortic valve replacement with the embolic protection system. In these centers, a patient can obtain services ranging from diagnosis, treatment, and effective post-surgery follow-up due to the availability of superior infrastructure compared to hospitals. This can be attributed to the highest growth rate of the specialty cardiac center segment.
The ability of ambulatory surgical centers to safely perform complex procedures by following backup protocols is expected to witness steady demand. The demand is growing in developed countries as the end-users are shifting from open surgeries to MI-based surgical techniques. The growth in technological advancements, less invasive surgeries, and outpatient services are contributing to the market growth of ASCs.
North America is the single largest market for embolic protection companies. The region has become strategically important for several prominent vendors, such as Boston Scientific and Abbott. Medtronic embolic protection devices are expected to be innovative as the company is investing significant expenditure in R&D. The US is the major revenue contributor to the market, accounted for a share of 90% in 2019.
Europe is the second-largest market for embolic protection devices and accounted for a share of 34% in 2019. It is growing at a healthy rate and is expected to grow at a similar pace during the forecast period. Germany, France, the UK, Spain, and Italy are the major revenue contributors to this region.
The APAC region was estimated to have 57% of the global elderly population in 2017. The percentage is projected to increase to 61% by 2050. Such a rapidly growing aging population will have a higher risk of having various cardiac disorders. The aging population will increase the demand for these devices during the forecast period.
The global embolic protection devices market share is highly concentrated. The market has the presence of few established players holding the majority of the market share. Vendors are offering several filter and occlusion embolic protection devices. They are competing based on factors such as technology advances, safety features, regulatory approvals, marketing strategies, and distribution channels.
Boston Scientific, Abbott Laboratories, and Medtronic are the key vendors in the global market. These companies have a wide geographic footprint, diversified product portfolio, and a strong focus on product innovations and R&D. Medtronic’s spiderfx device offers optimal vessel sizing.
By Product
By Application
By Indication
By End-user
By Geography
Embolic protection devices market size is expected reach revenues of over USD 688 million by 2025.
The rising demand for cerebral embolic protection devices is expected to drive the growth of the market.
Boston Scientific, Abbott Laboratories, and Medtronic are the key vendors in the global market.
North America is expected to witness the highest growth rate during the forecast period.
The embolic protection devices market share is expected to grow at a CAGR of over 8% during the period 2020–2025.
The following factors are likely to contribute to the growth of the embolic protection devices market during the forecast period:
Base Year: 2019
Forecast Year: 2020–2025
The study considers the present scenario of the embolic protection devices market and its market dynamics for the period 2019−2025. It covers a detailed overview of several market growth enablers, restraints, and trends. The study offers both the demand and supply aspect of the market. It profiles and examines leading companies and other prominent ones operating in the market.
Prominent Vendors
Other Prominent Vendors
Investigational Companies
Segmentation by Product
Segmentation by Application
Segmentation by Indication
Segmentation by End-user
Segmentation by Geography
1 Research Methodology
2 Research Objectives
3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusion
4.2 Base Year
4.3 Scope Of The Study
4.4 Markey Segments
4.4.1 Market Segmentation by Product
4.4.2 Market Segmentation by Application
4.4.3 Market Segmentation by Indication
4.4.4 Market Segmentation by End-user
4.4.5 Market Segmentation by Geography
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market at a Glance
7 Introduction
7.1 Embolic Protection Devices (EPDS): An Overview
7.1.1 Background
7.1.2 Use of EPDs
8 Market Opportunities & Trends
8.1 Emergence Of Advanced EPDs
8.2 Promising Investigational Devices
8.3 New Product Approval
9 Market Growth Enablers
9.1 Rising Patient Pool
9.2 Growing Demand For Cerebral Embolic Protection Devices
9.3 Rising Demand For Minimally Invasive Vascular Surgeries
10 Market Restraints
10.1 Stringent Regulations & Product Recalls
10.2 Risk & Complications Associated With Embolic Protection Devices
10.2.1 Complications Associated With Cardiovascular & Peripheral Procedures
10.2.2 Complications Associated With Neurovascular Procedures
10.3 Lower Than Expected Acceptance & Clinical Implementation
11 Market Landscape
11.1 Market Overview
11.2 Market Size & Forecast
11.2.1 Geographic Analysis
11.2.2 Product Analysis
11.2.3 Application Analysis
11.2.4 Indication Analysis
11.2.5 End User Analysis
11.3 Five Forces Analysis
11.3.1 Threat of New Entrants
11.3.2 Bargaining Power of Suppliers
11.3.3 Bargaining Power of Buyers
11.3.4 Threat of Substitutes
11.3.5 Competitive Rivalry
12 Product
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 Filter Devices
12.3.1 Market Overview
12.3.2 Market Size & Forecast
12.4 Occlusion Devices
12.4.1 Market Overview
12.4.2 Market Size & Forecast
13 Application
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Cardiovascular & Peripheral Applications
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.3.3 Geographic Market Snapshot & Growth Engine
13.4 Neurovascular Application
13.4.1 Market Overview
13.4.2 Market Size & Forecast
13.4.3 Geographic Market Snapshot & Growth Engine
14 Indication
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 SVG
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.4 Carotid Artery Disease
14.4.1 Market Overview
14.4.2 Market Size & Forecast
14.5 Others
14.5.1 Market Overview
14.5.2 Market Size & Forecast
15 End-User
15.1 Market Snapshot & Growth Engine
15.2 Market Overview
15.3 Hospitals
15.3.1 Market Overview
15.3.2 Market Size & Forecast
15.4 Specialty Cardiac Centers
15.4.1 Market Overview
15.4.2 Market Size & Forecast
15.5 ASCS
15.5.1 Market Overview
15.5.2 Market Size & Forecast
15.6 Freestanding Cath Labs
15.6.1 Market Overview
15.6.2 Market Size & Forecast
16 Geography
16.1 Market Snapshot & Growth Engine
16.2 Geographic Overview
17 North America
17.1 Market Overview
17.2 Market Size & Forecast
17.3 Application Segmentation
17.3.1 Market Snapshot & Growth Engine
17.4 Key Countries
17.4.1 US: Market Size & Forecast
17.4.2 Canada: Market Size & Forecast
18 Europe
18.1 Market Overview
18.2 Market Size & Forecast
18.3 Application Segmentation
18.3.1 Market Snapshot & Growth Engine
18.4 Key Countries
18.4.1 Germany: Market Size & Forecast
18.4.2 France: Market Size & Forecast
18.4.3 UK: Market Size & Forecast
18.4.4 Spain: Market Size & Forecast
18.4.5 Italy: Market Size & Forecast
19 APAC
19.1 Market Overview
19.2 Market Size & Forecast
19.3 Application Segmentation
19.3.1 Market Snapshot & Growth Engine
19.4 Key Countries
19.4.1 Japan: Market Size & Forecast
19.4.2 China: Market Size & Forecast
19.4.3 Australia: Market Size & Forecast
19.4.4 South Korea: Market Size & Forecast
19.4.5 India: Market Size & Forecast
20 Latin America
20.1 Market Overview
20.2 Market Size & Forecast
20.3 Application Segmentation
20.3.1 Market Snapshot & Growth Engine
20.4 Key Countries
20.4.1 Brazil: Market Size & Forecast
20.4.2 Mexico: Market Size & Forecast
20.4.3 Argentina: Market Size & Forecast
21 Middle East & Africa
21.1 Market Overview
21.2 Market Size & Forecast
21.3 Application Segmentation
21.3.1 Market Snapshot & Growth Engine
21.4 Key Countries
21.4.1 Turkey: Market Size & Forecast
21.4.2 Saudi Arabia: Market Size & Forecast
21.4.3 South Africa: Market Size & Forecast
22 Competitive Landscape
22.1 Competition Overview
22.2 Market Share Analysis
22.2.1 Boston Scientific
22.2.2 Abbott
22.2.3 Medtronic
23 Key Company Profiles
23.1 Boston Scientific
23.1.1 Business Overview
23.1.2 Product Offerings
23.1.3 Key Strategies
23.1.4 Key Strengths
23.1.5 Key Opportunities
23.2 Abbott
23.2.1 Business Overview
23.2.2 Product Offerings
23.2.3 Key Strategies
23.2.4 Key Strengths
23.2.5 Key Opportunities
23.3 Medtronic
23.3.1 Business Overview
23.3.2 Product Offerings
23.3.3 Key Strategies
23.3.4 Key Strengths
23.3.5 Key Opportunities
24 Other Prominent Vendors
24.1 Cardinal Health
24.1.1 Business Overview
24.1.2 Product Offerings
24.1.3 Key Strategies
24.1.4 Key Strengths
24.1.5 Key Opportunities
24.2 Cardiovascular Systems
24.2.1 Business Overview
24.2.2 Product Offerings
24.2.3 Key Strategies
24.2.4 Key Strengths
24.2.5 Key Opportunities
24.3 Contego Medical
24.3.1 Business Overview
24.3.2 Product Offerings
24.3.3 Key Strategies
24.3.4 Key Strengths
24.3.5 Key Opportunities
24.4 InspireMD
24.4.1 Business Overview
24.4.2 Product Offerings
24.4.3 Key Strategies
24.4.4 Key Strengths
24.4.5 Key Opportunities
24.5 NIPRO
24.5.1 Business Overview
24.5.2 Product Offerings
24.5.3 Key Strategies
24.5.4 Key Strengths
24.5.5 Key Opportunities
24.6 Silk Road Medical
24.6.1 Business Overview
24.6.2 Product Offerings
24.6.3 Key Strategies
24.6.4 Key Strengths
24.6.5 Key Opportunities
24.7 Terumo
24.7.1 Business Overview
24.7.2 Product Offerings
24.7.3 Key Strategies
24.7.4 Key Strengths
24.7.5 Key Opportunities
24.8 Venus Medtech
24.8.1 Business Overview
24.8.2 Product Offerings
24.8.3 Key Strategies
24.8.4 Key Strengths
24.8.5 Key Opportunities
25 Investigational Companies
25.1 Cardioptimus
25.1.1 Business Overview
25.1.2 Investigational Products
25.2 filterlex
25.2.1 Business Overview
25.2.2 Investigational Products
25.3 Innovative Cardiovascular Solutions
25.3.1 Business Overview
25.3.2 Investigational Products
25.4 Protembis
25.4.1 Business Overview
25.4.2 Investigational Products
25.5 Transverse Medical
25.5.1 Business Overview
25.5.2 Investigational Products
26 Report Summary
26.1 Key Takeaways
26.2 Strategic Recommendations
27 Quantitative Summary
27.1 Product
27.2 Application
27.3 Indication
27.4 End-User
27.5 Geography
27.6 North America: Application Segmentation
27.7 Europe: Application Segmentation
27.8 Apac: Application Segmentation
27.9 Latin America: Application Segmentation
27.1 Middle East & Africa: Application Segmentation
27.11 Cardiovascular & Peripheral: Geography Segmentation
27.12 Neurovascular: Geography Segmentation
28 Appendix
28.1 Abbreviations
List Of Exhibits
Exhibit 1 Segmentation of Global Embolic Protection Devices Market
Exhibit 2 Market Size Calculation Approach 2019
Exhibit 3 Classification of EPDs
Exhibit 4 Key Advantages of Embolic Protection Devices
Exhibit 5 Key Application Areas of EPDs
Exhibit 6 Major Market Dynamics of EPDs
Exhibit 7 Global Embolic Protection Devices Market by Geography 2019 (%)
Exhibit 8 Global Embolic Protection Devices Market by Product 2019 (%)
Exhibit 9 Impact of Emergence of Advanced EPDs
Exhibit 10 Impact of Promising Investigational Devices
Exhibit 11 Impact of New Product Approval
Exhibit 12 Impact of Rising Patient Pool
Exhibit 13 Prevalence of Aortic Valve Disease in Different Age Groups (%)
Exhibit 14 Prevalence of Aortic Regurgitation in Different Age groups
Exhibit 15 Impact of Growing Demand for Cerebral Embolic Protection Devices
Exhibit 16 Impact of Rising Demand for Minimally Invasive Vascular Surgeries
Exhibit 17 The MI Approach for Embolic Protection Devices Offers
Exhibit 18 Impact of Stringent Regulations & Product Recalls
Exhibit 19 Major Actions/Sanctions Imposed on Manufacturers by Regulatory Bodies
Exhibit 20 Impact of Risk & Complications Associated with Embolic Protection Devices
Exhibit 21 Impact of Lower Than Expected Acceptance & Clinical Implementation
Exhibit 22 Key Factors Hindering the Expected Market Penetration of EPDs in Developing Countries
Exhibit 23 Global Embolic Protection Devices Market Share by Region 2019 (%)
Exhibit 24 Global Embolic Protection Devices Market 2019–2025 ($ million)
Exhibit 25 Global Embolic Protection Devices Market by Geography
Exhibit 26 Global Embolic Protection Devices Market by Product
Exhibit 27 Global Embolic Protection Devices Market by Application
Exhibit 28 Global Embolic Protection Devices Market by Indication
Exhibit 29 Global Embolic Protection Devices Market by End-user
Exhibit 30 Five Forces Analysis 2019
Exhibit 31 Incremental Growth by Product 2019 & 2025
Exhibit 32 Global Embolic Protection Devices Market by Product
Exhibit 33 Global Embolic Protection Devices Market by Product: Incremental Growth
Exhibit 34 Global Embolic Protection Devices Market by Product: Absolute Growth
Exhibit 35 Global Filter Embolic Protection Devices Market: Incremental & Absolute Growth
Exhibit 36 Key Advantages of Filter Devices for Embolic Protection
Exhibit 37 Global Filter Embolic Protection Devices Market 2019–2025 ($ million)
Exhibit 38 Global Occlusion Embolic Protection Devices Market: Incremental & Absolute Growth
Exhibit 39 Key Advantages of Occlusion Devices
Exhibit 40 Global Occlusion Embolic Protection Devices Market 2019–2025 ($ million)
Exhibit 41 Incremental Growth by Application 2019 & 2025
Exhibit 42 Global Embolic Protection Devices Market by Application
Exhibit 43 Global Embolic Protection Devices Market by Application: Incremental Growth
Exhibit 44 Global Embolic Protection Devices Market by Application: Absolute Growth
Exhibit 45 Global Cardiovascular & Peripheral Embolic Protection Devices Market: Incremental & Absolute Growth
Exhibit 46 Global Embolic Protection Devices Market for Cardiovascular & Peripheral Applications 2019–2025 ($ million)
Exhibit 47 Benefits of Prevention of Microvascular Obstruction with Embolic Protection Devices in SVG PCI
Exhibit 48 Incremental Growth by Geography 2019 & 2025
Exhibit 49 Cardiovascular & Peripheral Embolic Protection Devices Market by Geography 2019 & 2025 (%)
Exhibit 50 Neurovascular Embolic Protection Devices Market: Incremental & Absolute Growth
Exhibit 51 Global Embolic Protection Devices Market for Neurovascular Application 2019–2025 ($ million)
Exhibit 52 Incremental Growth by Geography 2019 & 2025
Exhibit 53 Global Neurovascular Embolic Protection Devices Market by Geography 2019 & 2025 (%)
Exhibit 54 Incremental Growth by Indication 2019 & 2025
Exhibit 55 Global Embolic Protection Devices Market by Indication
Exhibit 56 Global Embolic Protection Devices Market by Indication: Incremental Growth
Exhibit 57 Global Embolic Protection Devices Market by Indication: Absolute Growth
Exhibit 58 Global Embolic Protection Devices Market for SVG: Incremental & Absolute Growth
Exhibit 59 Key Strengths of EPDs for SVG
Exhibit 60 Global Embolic Protection Devices Market for SVG 2019–2025 ($ million)
Exhibit 61 Embolic Protection Devices Market for Carotid Artery Disease: Incremental & Absolute Growth
Exhibit 62 Global Embolic Protection Devices Market for Carotid Artery Disease 2019–2025 ($ million)
Exhibit 63 Global Embolic Protection Devices Market for Other Indications: Incremental & Absolute Growth
Exhibit 64 Potential Advantages of EPDs for TAVR Procedure
Exhibit 65 Global Embolic Protection Devices Market for Other Indications 2019–2025 ($ million)
Exhibit 66 Incremental Growth by End-user 2019 & 2025
Exhibit 67 Global Embolic Protection Devices Market by End-user
Exhibit 68 Global Embolic Protection Devices Market by End-user: Incremental Growth
Exhibit 69 Global Embolic Protection Devices Market by End-user: Absolute Growth
Exhibit 70 Global Embolic Protection Devices Market by Hospitals: Incremental & Absolute Growth
Exhibit 71 Global Embolic Protection Devices Market by Hospitals 2019–2025 ($ million)
Exhibit 72 Global Embolic Protection Devices Market by Specialty Cardiac Centers: Incremental & Absolute Growth
Exhibit 73 Global Embolic Protection Devices Market by Specialty Cardiac Centers 2019–2025 ($ million)
Exhibit 74 Global Embolic Protection Devices Market by ASCs: Incremental & Absolute Growth
Exhibit 75 Global Embolic Protection Devices Market by ASCs 2019–2025 ($ million)
Exhibit 76 Global Embolic Protection Devices Market by Freestanding CATH Labs: Incremental & Absolute Growth
Exhibit 77 Global Embolic Protection Devices Market by Freestanding CATH Labs 2019–2025 ($ million)
Exhibit 78 Incremental Growth by Geography 2019 & 2025
Exhibit 79 Global Embolic Protection Devices Market by Geography
Exhibit 80 Global Embolic Protection Devices Market by Geography 2019: Key Countries ($ million)
Exhibit 81 Global Embolic Protection Devices Market by Geography: Incremental Growth
Exhibit 82 Global Embolic Protection Devices Market by Geography: Absolute Growth
Exhibit 83 Embolic Protection Devices Market in North America: Key Countries 2019 ($ million)
Exhibit 84 North America Embolic Protection Devices Market: Absolute & Incremental Growth
Exhibit 85 Embolic Protection Devices Market in North America 2019–2025 ($ million)
Exhibit 86 Incremental Growth by Application 2019 & 2025
Exhibit 87 North America Embolic Protection Devices Market by Application 2019 & 2025 (%)
Exhibit 88 Incremental Growth in North America 2019 & 2025
Exhibit 89 Embolic Protection Devices Market in US 2019–2025 ($ million)
Exhibit 90 Embolic Protection Devices Market in Canada 2019–2025 ($ million)
Exhibit 91 Embolic Protection Devices Market in Europe: Key Countries 2019 ($ million)
Exhibit 92 Embolic Protection Devices Market in Europe: Incremental & Absolute Growth
Exhibit 93 Embolic Protection Devices Market in Europe 2019–2025 ($ million)
Exhibit 94 Incremental Growth by Application 2019 & 2025
Exhibit 95 Embolic Protection Devices Market in Europe by Application 2019 & 2025 (%)
Exhibit 96 Incremental Growth in Europe 2019 & 2025
Exhibit 97 Embolic Protection Devices Market in Germany 2019–2025 ($ million)
Exhibit 98 Embolic Protection Devices Market in France 2019–2025 ($ million)
Exhibit 99 Embolic Protection Devices Market in UK 2019–2025 ($ million)
Exhibit 100 Embolic Protection Devices Market in Spain 2019–2025 ($ million)
Exhibit 101 Embolic Protection Devices Market in Italy 2019–2025 ($ million)
Exhibit 102 Embolic Protection Devices Market in APAC: Key Countries 2019 ($ million)
Exhibit 103 Embolic Protection Devices Market in APAC: Incremental & Absolute Growth
Exhibit 104 Embolic Protection Devices Market in APAC 2019–2025 ($ million)
Exhibit 105 Health Access & Quality Index Score for Key APAC Countries 2016
Exhibit 106 Incremental Growth by Application 2019 & 2025
Exhibit 107 Embolic Protection Devices Market in APAC by Application 2019 & 2025 (%)
Exhibit 108 Incremental Growth in APAC 2019 & 2025
Exhibit 109 Embolic Protection Devices Market in Japan 2019–2025 ($ million)
Exhibit 110 Embolic Protection Devices Market in China 2019–2025 ($ million)
Exhibit 111 Embolic Protection Devices Market in Australia 2019–2025 ($ million)
Exhibit 112 Embolic Protection Devices Market in South Korea 2019–2025 ($ million)
Exhibit 113 Embolic Protection Devices Market in India 2019–2025 ($ million)
Exhibit 114 Embolic Protection Devices Market in Latin America: Key Countries 2019 ($ million)
Exhibit 115 Embolic Protection Devices Market in Latin America: Incremental & Absolute Growth
Exhibit 116 Embolic Protection Devices Market in Latin America 2019–2025 ($ million)
Exhibit 117 Incremental Growth by Application 2019 & 2025
Exhibit 118 Latin America Embolic Protection Devices Market by Application 2019 & 2025 (%)
Exhibit 119 Incremental Growth in Latin America 2019 & 2025
Exhibit 120 Embolic Protection Devices Market in Brazil 2019–2025 ($ million)
Exhibit 121 Embolic Protection Devices Market in Mexico 2019–2025 ($ million)
Exhibit 122 Embolic Protection Devices Market in Argentina 2019–2025 ($ million)
Exhibit 123 Embolic Protection Devices Market in Middle East & Africa: Key Countries 2019 ($ million)
Exhibit 124 Embolic Protection Devices Market in Middle East & Africa: Incremental & Absolute Growth
Exhibit 125 Embolic Protection Devices Market in Middle East & Africa 2019–2025 ($ million)
Exhibit 126 Incremental Growth by Application 2019 & 2025
Exhibit 127 Embolic Protection Devices Market in Middle East & Africa by Application 2019 & 2025 (%)
Exhibit 128 Incremental Growth in Middle East & Africa 2019 & 2025
Exhibit 129 Embolic Protection Devices Market in Turkey 2019–2025 ($ million)
Exhibit 130 Embolic Protection Devices Market in Saudi Arabia 2019–2025 ($ million)
Exhibit 131 Embolic Protection Devices Market in South Africa 2019–2025 ($ million)
Exhibit 132 Market Share (2019)
Exhibit 133 Boston Scientific: R&D Expenditure 2017−2019 ($ million)
Exhibit 134 Boston Scientific: Revenue by Business Segments 2018 & 2019 ($ million)
Exhibit 135 Boston Scientific: Revenue by Geography 2019 (%)
Exhibit 136 Abbott: R&D Expenditure 2017−2019 ($ million)
Exhibit 137 Abbott: Revenue by Segments 2018 & 2019 ($ million)
Exhibit 138 Abbott: Revenue by Geography 2019 (%)
Exhibit 139 Medtronic: R&D Expenditure 2017−2019 ($ million)
Exhibit 140 Medtronic: Revenue by Segment 2018 & 2019 ($ million)
Exhibit 141 Medtronic: Revenue by Geography 2019 (%)
Exhibit 142 Cardinal Health: Revenue by Segment 2018 & 2019 ($ million)
Exhibit 143 Cardinal Health: Revenue by Geography 2019 (%)
Exhibit 144 Cardiovascular Systems: R&D Expenditure 2017−2019 ($ million)
Exhibit 145 Cardiovascular Systems: Revenue by Product Type 2018 & 2019 ($ million)
Exhibit 146 Cardiovascular Systems: Revenue by Geography 2019 (%)
Exhibit 147 InspireMD: R&D Expenditure 2017−2019 ($ million)
List Of Tables
Table 1 Key Caveats
Table 2 Currency Conversion 2013−2019
Table 3 Key Advanced Embolic Protection Devices
Table 4 Major Embolic Protection Devices Pipeline
Table 5 List of New Product Approval
Table 6 Mechanisms of Stroke in TAVR Patients
Table 7 Key Cerebral Embolic Protection Devices Offered by Significant Vendors
Table 8 Key Investigational Cerebral Embolic Protection Devices
Table 9 Significant Product Recalls
Table 10 Market Penetration of EPDs by Region 2019 (%)
Table 11 Key Embolic Protection Filter Devices
Table 12 Significant Occlusion Embolic Protection Devices Offered by Market Players
Table 13 Key Cardiovascular & Peripheral EPDs Offered by Significant Players
Table 14 Cardiovascular & Peripheral Embolic Protection Devices Market by Geography 2019−2025 ($ million)
Table 15 Cardiovascular & Peripheral Embolic Protection Devices Market by Geography 2019−2025 (%)
Table 16 Key Neurovascular EPDs Offered by Significant Players
Table 17 Global Neurovascular Embolic Protection Devices Market by Geography 2019−2025 ($ million)
Table 18 Global Neurovascular Embolic Protection Devices Market by Geography 2019−2025 (%)
Table 19 Vendors Offering EPDs for SVG Indications
Table 20 Vendors Offering EPDs for Carotid Artery Disease
Table 21 North America Embolic Protection Devices Market by Application 2019−2025 ($ million)
Table 22 North America Embolic Protection Devices Market by Application 2019−2025 (%)
Table 23 Europe Embolic Protection Devices Market in Europe by Application 2019−2025 ($ million)
Table 24 Embolic Protection Devices Market in Europe by Application 2019−2025 (%)
Table 25 Embolic Protection Devices Market in APAC by Application 2019−2025 ($ million)
Table 26 Embolic Protection Devices Market in APAC by Application 2019−2025 (%)
Table 27 Provincial Reimbursement Policy in China
Table 28 Latin America Embolic Protection Devices Market by Application 2019−2025 ($ million)
Table 29 Latin America Embolic Protection Devices Market by Application 2019−2025 (%)
Table 30 Embolic Protection Devices Market in Middle East & Africa by Application 2019−2025 ($ million)
Table 31 Embolic Protection Devices Market in Middle East & Africa by Application 2019−2025 (%)
Table 32 Competitive Structure of Global Embolic Protection Devices Market
Table 33 Global Embolic Protection Devices Market: Vendors Ranking 2019
Table 34 Boston Scientific: Major Product Offerings
Table 35 Abbott: Major Product Offerings
Table 36 Medtronic: Major Product Offerings
Table 37 Cardinal Health: Major Product Offerings
Table 38 Cardiovascular Systems: Major Product Offerings
Table 39 Contego Medical: Major Product Offerings
Table 40 InspireMD: Major Product Offerings
Table 41 NIPRO: Major Product Offerings
Table 42 Silk Road Medical: Major Product Offerings
Table 43 Terumo: Major Product Offerings
Table 44 Venus Medtech: Major Product Offerings
Table 45 Cardioptimus: Major Investigational Products
Table 46 Filterlex: Major Investigational Products
Table 47 Innovative Cardiovascular Solutions: Major Investigational Products
Table 48 Protembis: Major Investigational Products
Table 49 Transverse Medical: Major Investigational Products
Table 50 Global Embolic Protection Devices Market by Product 2019−2025 ($ million)
Table 51 Global Embolic Protection Devices Market by Product 2019−2025 (%)
Table 52 Global Embolic Protection Devices Market by Application 2019−2025 ($ million)
Table 53 Global Embolic Protection Devices Market by Application 2019−2025 (%)
Table 54 Global Embolic Protection Devices Market by Indication 2019−2025 ($ million)
Table 55 Global Embolic Protection Devices Market by Indication 2019−2025 (%)
Table 56 Global Embolic Protection Devices Market by End-user 2019−2025 ($ million)
Table 57 Global Embolic Protection Devices Market by End-user 2019−2025 (%)
Table 58 Global Embolic Protection Devices Market by Geography 2019−2025 ($ million)
Table 59 Global Embolic Protection Devices Market by Geography 2019−2025 (%)
Table 60 North America Embolic Protection Devices Market by Application 2019−2025 ($ million)
Table 61 North America Embolic Protection Devices Market by Application 2019−2025 (%)
Table 62 Europe Embolic Protection Devices Market by Application 2019−2025 ($ million)
Table 63 Europe Embolic Protection Devices Market by Application 2019−2025 (%)
Table 64 APAC Embolic Protection Devices Market by Application 2019−2025 ($ million)
Table 65 APAC Embolic Protection Devices Market by Application 2019−2025 (%)
Table 66 Latin America Embolic Protection Devices Market by Application 2019−2025 ($ million)
Table 67 Latin America Embolic Protection Devices Market by Application 2019−2025 (%)
Table 68 Middle East & Africa Embolic Protection Devices Market by Application 2019−2025 ($ million)
Table 69 Middle East & Africa Embolic Protection Devices Market by Application 2019−2025 (%)
Table 70 Cardiovascular & Peripheral Embolic Protection Devices Market by Geography 2019−2025 ($ million)
Table 71 Cardiovascular & Peripheral Embolic Protection Devices Market by Geography 2019−2025 (%)
Table 72 Neurovascular Embolic Protection Devices Market by Geography 2019−2025 ($ million)
Table 73 Neurovascular Embolic Protection Devices Market by Geography 2019−2025 (%)
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
